TENAX THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Tenax Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q1 2011 to Q3 2024.
  • Tenax Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $1.12K, unchanged year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.12K $0 0% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.12K $0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.12K $0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.12K -$8.44K -88.3% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $1.12K -$7.32K -86.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.12K -$7.32K -86.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.12K -$7.32K -86.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $9.55K +$1.12K +13.2% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $8.44K $0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $8.44K $0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $8.44K $0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $8.44K $0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $8.44K $0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $8.44K $0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $8.44K $0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $8.44K $0 0% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $8.44K $0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $8.44K $0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $8.44K $0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $8.44K $0 0% Dec 31, 2019 10-K/A 2021-04-16
Q3 2019 $8.44K $0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $8.44K $0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $8.44K $0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $8.44K $0 0% Dec 31, 2018 10-K 2020-03-30
Q3 2018 $8.44K +$5.67K +205% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $8.44K -$1.1M -99.2% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $8.44K -$1.1M -99.2% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $8.44K -$1.1M -99.2% Dec 31, 2017 10-K 2019-04-01
Q3 2017 $2.76K -$1.1M -99.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.11M $0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.11M $0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $1.11M $0 0% Dec 31, 2016 10-K 2018-04-02
Q3 2016 $1.11M $0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.11M $0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $1.11M $0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $1.11M -$50K -4.32% Dec 31, 2015 10-K 2017-03-16
Q3 2015 $1.11M -$50K -4.32% Oct 31, 2015 10-Q 2015-12-10
Q2 2015 $1.11M +$1.05M +1998% Jul 31, 2015 10-Q 2015-09-09
Q1 2015 $1.11M +$1.05M +1998% Apr 30, 2015 10-KT 2016-03-14
Q4 2014 $1.16M +$1.1M +1885% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 $1.16M +$1.1M +1885% Oct 31, 2014 10-Q 2014-12-15
Q2 2014 $52.8K -$5.5K -9.44% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 $52.8K -$5.5K -9.44% Apr 30, 2014 10-KT 2016-03-14
Q4 2013 $58.3K $0 0% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $58.3K $0 0% Oct 31, 2013 10-Q 2013-12-17
Q2 2013 $58.3K -$7.4K -11.3% Jul 31, 2013 10-Q 2013-09-17
Q1 2013 $58.3K -$7.4K -11.3% Apr 30, 2013 10-K 2014-07-29
Q4 2012 $58.3K -$7.4K -11.3% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 $58.3K -$91.4K -61.1% Oct 31, 2012 10-Q 2012-12-14
Q2 2012 $65.7K -$95.8K -59.3% Jul 31, 2012 10-Q 2012-09-19
Q1 2012 $65.7K -$81.9K -55.5% Apr 30, 2012 10-K 2013-06-26
Q4 2011 $65.7K Jan 31, 2012 10-Q 2012-03-15
Q3 2011 $150K Oct 31, 2011 10-Q 2011-12-15
Q2 2011 $162K Jul 31, 2011 10-Q 2011-09-19
Q1 2011 $148K Apr 30, 2011 10-K 2012-07-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.